OTCMKTS:FSDDF FSD Pharma (FSDDF) Stock Price, News & Analysis $13.00 -1.06 (-7.51%) As of 09/8/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About FSD Pharma Stock (OTCMKTS:FSDDF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get FSD Pharma alerts:Sign Up Key Stats Today's Range$12.14▼$13.9050-Day Range$13.00▼$29.2152-Week Range$3.43▼$68.66Volume221,509 shsAverage Volume11,100 shsMarket Capitalization$98.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview FSD Pharma Inc. is a clinical‐stage pharmaceutical company focused on the research, development and commercialization of cannabinoid‐based drug formulations and wellness products. Its team combines expertise in pharmaceutical R&D and cannabis science to advance novel therapeutic candidates derived from cannabidiol (CBD) and related cannabinoids. Through Canadian subsidiaries holding production licenses under the Cannabis Act, FSD Pharma operates extract and formulation facilities that manufacture full‐spectrum CBD oils, topicals and nutraceuticals. The company also collaborates with contract research organizations and academic partners to support preclinical studies and early‐phase clinical trials targeting a range of therapeutic areas. FSD Pharma distributes medical and wellness offerings across North America and has pursued partnerships and licensing agreements to extend its presence into Europe and other regulated markets. By integrating in‐house production capabilities with third‐party distribution networks, it aims to serve both patient and consumer segments with pharmaceutical‐grade cannabinoid solutions. Incorporated in Canada and trading on the OTC market under the ticker FSDDF, FSD Pharma is guided by a management team with backgrounds in pharmaceutical development, regulatory affairs and cannabis cultivation. The company continues to build its pipeline through strategic alliances, positioning itself within the emerging global cannabinoid therapeutics sector.AI Generated. May Contain Errors. Read More Receive FSDDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FSD Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FSDDF Stock News HeadlinesFreya Pharma Solutions Strengthens Leadership with Appointment of Distinguished Supervisory BoardJanuary 28, 2025 | markets.businessinsider.comQNTM Quantum BioPharma Ltd.August 31, 2024 | seekingalpha.comWall Street legend: “Put $1,000 in this AI stock”A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW kind of AI stock.September 10 at 2:00 AM | Chaikin Analytics (Ad)FSD Pharma Inc. (HUGE)May 17, 2024 | finance.yahoo.comFSD Pharma Inc. Obtains Final Order for Plan of ArrangementNovember 27, 2023 | benzinga.comFSD Pharma gets court complaint alleging breach of nondisclosure agreementMay 12, 2023 | msn.comFSD Pharma Inc Ordinary Shares - Class B (Sub Voting)March 31, 2023 | morningstar.comMFSD Pharma's Australian Entity To Proceed With Phase I Trial For Major Depressive DisorderMarch 23, 2023 | benzinga.comSee More Headlines FSDDF Stock Analysis - Frequently Asked Questions How have FSDDF shares performed this year? FSD Pharma's stock was trading at $3.68 on January 1st, 2025. Since then, FSDDF stock has increased by 253.3% and is now trading at $13.00. How do I buy shares of FSD Pharma? Shares of FSDDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Agricultural Commodities & Milling Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:FSDDF Previous SymbolOTCMKTS:FSDDF CIKN/A WebN/A Phone(416) 854-8884FaxN/AEmployees10Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.81 Quick Ratio1.60 Sales & Book Value Annual Sales$70 thousand Price / Sales1,407.71 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares7,580,000Free FloatN/AMarket Cap$98.54 million OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:FSDDF) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FSD Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share FSD Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.